Herantis Pharma Oyj (HRTIS.HE)

EUR 1.66

(0.91%)

Gross Profit Summary of Herantis Pharma Oyj

Herantis Pharma Oyj's latest annual gross profit in 2023 was - EUR , down 0.0% from previous year.
Herantis Pharma Oyj's latest quarterly gross profit in 2024 Q2 was - EUR , down 0.0% from previous quarter.
Herantis Pharma Oyj reported a annual gross profit of - EUR in annual gross profit 2022, down 0.0% from previous year.
Herantis Pharma Oyj reported a annual gross profit of - EUR in annual gross profit 2021, up 100.0% from previous year.
Herantis Pharma Oyj reported a quarterly gross profit of - EUR for 2024 Q2, down 0.0% from previous quarter.
Herantis Pharma Oyj reported a quarterly gross profit of - EUR for 2023 FY, down 0.0% from previous quarter.

Annual Gross Profit Chart of Herantis Pharma Oyj (2023 - 2011)

Historical Annual Gross Profit of Herantis Pharma Oyj (2023 - 2011)

Year	Gross Profit	Gross Profit Growth
2023	- EUR	0.0%
2022	- EUR	0.0%
2021	- EUR	100.0%
2020	-927.7 Thousand EUR	11.36%
2019	-1.04 Million EUR	12.96%
2018	-1.2 Million EUR	1.24%
2017	-1.21 Million EUR	-67659.77%
2016	-1797.00 EUR	99.98%
2015	-11.26 Million EUR	-1408383.63%
2014	- EUR	0.0%
2013	- EUR	-100.0%
2012	43.91 EUR	0.0%
2011	- EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	- EUR	0.0%
2024 Q2	- EUR	0.0%
2023 FY	- EUR	0.0%
2023 Q3	- EUR	0.0%
2023 Q4	- EUR	0.0%
2023 Q2	- EUR	0.0%
2023 Q1	- EUR	0.0%
2022 Q2	- EUR	0.0%
2022 Q1	- EUR	100.0%
2022 FY	- EUR	0.0%
2022 Q4	- EUR	0.0%
2022 Q3	- EUR	0.0%
2021 Q4	-80 Thousand EUR	0.0%
2021 Q1	- EUR	100.0%
2021 FY	- EUR	100.0%
2021 Q3	- EUR	100.0%
2021 Q2	-464 Thousand EUR	0.0%
2020 Q2	-463.85 Thousand EUR	0.0%
2020 Q4	-464 Thousand EUR	0.0%
2020 FY	-927.7 Thousand EUR	11.36%
2020 Q1	- EUR	100.0%
2020 Q3	- EUR	100.0%
2019 Q2	-562.18 Thousand EUR	0.0%
2019 Q3	- EUR	100.0%
2019 FY	-1.04 Million EUR	12.96%
2019 Q1	- EUR	0.0%
2019 Q4	-484.46 Thousand EUR	0.0%
2018 Q3	- EUR	0.0%
2018 Q4	- EUR	0.0%
2018 FY	-1.2 Million EUR	1.24%
2018 Q2	- EUR	0.0%
2018 Q1	- EUR	0.0%
2017 FY	-1.21 Million EUR	-67659.77%
2017 Q4	- EUR	0.0%
2017 Q3	- EUR	0.0%
2017 Q2	- EUR	0.0%
2017 Q1	- EUR	100.0%
2016 Q2	12.64 Thousand EUR	-0.01%
2016 FY	-1797.00 EUR	99.98%
2016 Q4	-13.54 Thousand EUR	0.0%
2016 Q3	-13.54 Thousand EUR	-207.11%
2016 Q1	12.64 Thousand EUR	1480.75%
2015 Q3	400.00 EUR	-30.68%
2015 FY	-11.26 Million EUR	-1408383.63%
2015 Q1	578.00 EUR	44.5%
2015 Q2	577.00 EUR	-0.17%
2015 Q4	800.00 EUR	100.0%
2014 Q1	- EUR	0.0%
2014 Q3	400.00 EUR	0.0%
2014 Q2	- EUR	0.0%
2014 Q4	400.00 EUR	0.0%
2014 FY	800.00 EUR	0.0%
2013 FY	- EUR	-100.0%
2013 Q4	- EUR	0.0%
2013 Q1	- EUR	0.0%
2013 Q3	- EUR	0.0%
2013 Q2	- EUR	0.0%
2012 FY	43.91 EUR	0.0%
2011 FY	- EUR	0.0%

Peer Gross Profit Comparison of Herantis Pharma Oyj

Name	Gross Profit	Gross Profit Difference
Biohit Oyj	3.97 Million EUR	100.0%
Nanoform Finland Oyj	1.71 Million EUR	100.0%